SCHEMBL24944783

SCHEMBL24944783

CNc1nc(Nc2ccc(CN3CCOCC3)cc2F)c(C(N)=O)nc1-c1cncc2c1ncn2C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 7/20 0.41
▸ CCNC P24863 2/20 0.37
▸ CDK8 P49336 2/20 0.37
▸ GRM2 Q14416 1/20 0.36
▸ MAPK9 P45984 1/20 0.35
▸ MAPK10 P53779 1/20 0.35
▸ RET P07949 1/20 0.35
▸ ROS1 P08922 1/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ EML4 Q9HC35 1/20 0.35
▸ ALK Q9UM73 1/20 0.35
▸ CSF1R P07333 1/20 0.35
▸ SYK P43405 2/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ TYK2 P29597 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ EGFR P00533 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ PDGFRA P16234 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL29173332 0.97 LRRK2 (0.39) LRRK2CCNCCDK8GRM2MAPK9
Formic Acid SCHEMBL30205467 0.97 LRRK2 (0.39) LRRK2CCNCCDK8GRM2MAPK9
SCHEMBL24944786 0.93 IKBKE (0.38) GRM2RETROS1FLT3EML4
SCHEMBL29173386 0.92 LRRK2 (0.43) LRRK2CCNCCDK8SYKJAK2
SCHEMBL30206109 0.92 LRRK2 (0.43) LRRK2CCNCCDK8SYKJAK2
SCHEMBL24944494 0.92 LRRK2 (0.42) LRRK2CCNCCDK8ALKSYK
SCHEMBL24944993 0.90 LRRK2 (0.40) LRRK2CCNCCDK8GRM2ALK
SCHEMBL24944183 0.89 SYK (0.44) CCNCCDK8FLT3EML4ALK
SCHEMBL30205579 0.89 SYK (0.44) CCNCCDK8FLT3EML4ALK
SCHEMBL24944784 0.88 LRRK2 (0.36) LRRK2CCNCCDK8GRM2RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback